Axonics to Present at the J.P. Morgan Healthcare Conference

Rhea-AI Summary

Axonics, Inc. (Nasdaq: AXNX) to Present at J.P. Morgan Healthcare Conference

IRVINE, Calif.--(BUSINESS WIRE)-- Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, is scheduled to present at the J.P. Morgan Healthcare conference at 5:15 p.m. Pacific Time on Monday, January 8, 2024.

Interested parties may access a live webcast and replay of the presentation by visiting the Axonics investor relations website.

About Axonics

Axonics is a global medical technology company that is developing and commercializing novel products for adults with bladder and bowel dysfunction. Axonics recently ranked No. 2 on the 2023 Financial Times list of the fastest growing companies in the Americas after being ranked No. 1 in 2022.

Axonics^® sacral neuromodulation systems provide adults with overactive bladder and/or fecal incontinence with long-lived, easy to use, safe, clinically effective therapy. In addition, the company’s best-in-class urethral bulking hydrogel, Bulkamid^®, provides safe and durable symptom relief to women with stress urinary incontinence. In the U.S., moderate to severe urinary incontinence affects an estimated 28 million women and fecal incontinence affects an estimated 19 million adults. For more information, visit www.axonics.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20231227494865/en/

Neil Bhalodkar

949-336-5293

IR@axonics.com

Source: Axonics, Inc.

FAQ

What is the company name and ticker symbol presenting at the J.P. Morgan Healthcare conference?

The company presenting at the J.P. Morgan Healthcare conference is Axonics, Inc. (Nasdaq: AXNX).

When is the presentation scheduled for the J.P. Morgan Healthcare conference?

The presentation is scheduled for 5:15 p.m. Pacific Time on Monday, January 8, 2024.

How can interested parties access the presentation?

Interested parties can access a live webcast and replay of the presentation by visiting the Axonics investor relations website.